Fatal Bladder Carcinoma in Woman with Human Immunodeficiency Virus: A Case Report

Authors

  • O Bjane Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco. Author
  • M Ibrahim Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco.  Author
  • A Elouadih Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco. Author
  • A Kbiro Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco.  Author
  • A Moataz Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco.   Author
  • M Dakir Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco. Author
  • A Debbagh Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco.   Author
  • R Aboutaieb Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco.  Author

DOI:

https://doi.org/10.47363/JCRR/2024(6)200

Keywords:

Fatal Bladder Carcinoma , Human Immunodeficiency

Abstract

Background: Chronic human immunodeficiency virus (HIV) infection is associated with an increased incidence of Non-Acquired Immunodeficiency Syndrome (non-AIDS) defining cancers. To date, only a limited number of cases of bladder cancer have been linked with HIV infection in women. We sought to describe the clinical characteristics of HIV-associated bladder cancer.

Methods: A 54-year-old female patient presented with symptoms of an occlusive syndrome. Medical examination was followed by a CT scan. The imaging revealed a significant finding. There was a noticeable process within the bladder. Further evaluation and management were recommended.

Results: Spontaneous urinary cytology revealed the presence of malignant cells. An endoscopy was performed under spinal anesthesia, uncovering a large sessile tumor with necrotic areas located on the ventral aspect and dome of the bladder. Due to the severity of the condition, a palliative resection was carried out. Subsequent histological examination identified the tumor as a high-grade urothelial carcinoma, with evidence of muscle invasion. This diagnosis confirmed the aggressive nature of the disease, highlighting the necessity for further medical management and intervention.

Conclusion: Bladder cancers in HIV-infected patients are rare but can occur in relatively young individuals with a low nadir CD4 cell count. These cancers often exhibit aggressive pathological features and can be fatal.

Author Biographies

  • O Bjane, Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco.

    O Bjane, Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco.

  • M Ibrahim, Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco. 

    M Ibrahim, Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco. 

  • A Elouadih, Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco.

    A Elouadih, Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco.

  • A Kbiro, Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco. 

    A Kbiro, Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco. 

  • A Moataz, Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco.  

    A Moataz, Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco.  

  • M Dakir, Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco.

    M Dakir, Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco.

  • A Debbagh, Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco.  

    A Debbagh, Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco.  

  • R Aboutaieb, Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco. 

    R Aboutaieb, Urology Department, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan Ii University, Casablanca, Morocco. 

Downloads

Published

2024-08-26